Cargando…
Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852326/ https://www.ncbi.nlm.nih.gov/pubmed/35185871 http://dx.doi.org/10.3389/fimmu.2022.757802 |
_version_ | 1784653019800928256 |
---|---|
author | Zhang, Suo Chen, Yu-Lan Liu, Cui-Lian Xie, Jing-Yi Sun, Bao-Dong Liu, Dong-Zhou |
author_facet | Zhang, Suo Chen, Yu-Lan Liu, Cui-Lian Xie, Jing-Yi Sun, Bao-Dong Liu, Dong-Zhou |
author_sort | Zhang, Suo |
collection | PubMed |
description | Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1γ antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors’ knowledge, this is the first case study describing a patient with anti-TIF1γ antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1γ-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1γ-positive dermatomyositis. |
format | Online Article Text |
id | pubmed-8852326 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88523262022-02-18 Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis Zhang, Suo Chen, Yu-Lan Liu, Cui-Lian Xie, Jing-Yi Sun, Bao-Dong Liu, Dong-Zhou Front Immunol Immunology Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1γ antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors’ knowledge, this is the first case study describing a patient with anti-TIF1γ antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1γ-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1γ-positive dermatomyositis. Frontiers Media S.A. 2022-02-03 /pmc/articles/PMC8852326/ /pubmed/35185871 http://dx.doi.org/10.3389/fimmu.2022.757802 Text en Copyright © 2022 Zhang, Chen, Liu, Xie, Sun and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zhang, Suo Chen, Yu-Lan Liu, Cui-Lian Xie, Jing-Yi Sun, Bao-Dong Liu, Dong-Zhou Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title | Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title_full | Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title_fullStr | Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title_full_unstemmed | Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title_short | Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis |
title_sort | case report: iga nephropathy in a patient with anti-transcription intermediary factor-1γ antibody-positive dermatomyositis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852326/ https://www.ncbi.nlm.nih.gov/pubmed/35185871 http://dx.doi.org/10.3389/fimmu.2022.757802 |
work_keys_str_mv | AT zhangsuo casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis AT chenyulan casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis AT liucuilian casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis AT xiejingyi casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis AT sunbaodong casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis AT liudongzhou casereportiganephropathyinapatientwithantitranscriptionintermediaryfactor1gantibodypositivedermatomyositis |